Released | Company | Title | Industry | Topic |
---|---|---|---|---|
29 Apr 2021 16:15 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS Q1-2021 Presentation | 20103010 Biotechnology | Non-regulatory press releases |
29 Apr 2021 07:00 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: First Quarter 2021 Results | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
26 Apr 2021 13:58 CEST |
SOFTOX SOLUTIONS | Presentation of SoftOx Solution AS First quarter 2021 Results | 20103010 Biotechnology | Non-regulatory press releases |
13 Apr 2021 19:46 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Protokoll fra generalforsamling | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
09 Apr 2021 08:00 CEST |
SOFTOX SOLUTIONS | SOFTOX SOLUTIONS AS: NATIONAL COMMITTEE ON HEALTH RESEARCH ETHICS APPROVES FIRST-IN-HUMAN CLINICAL STUDY FOR SOFTOX WOUND TREATMENT AGENT FOR CHRONIC WOUNDS, BIOFILM ERADICATOR (SBE) | 20103010 Biotechnology | Non-regulatory press releases |
06 Apr 2021 09:00 CEST |
SOFTOX SOLUTIONS | SOFTOX SOLUTIONS AS: NOTICE OF ANNUAL GENERAL MEETING | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
06 Apr 2021 08:45 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Annual Report 2020 | 20103010 Biotechnology | Annual financial and audit Reports |